Noveris Health Sciences Inc. MYCOF
Set alert
0.80 USD +0.07 +9.59%
At close · Oct 30
0.80 Day range 0.80
0.096 52-week range 2.04
- YTD
- +266.97%
- 1 year
- +238.98%
- Open
- 0.80
- Prev close
- 0.73
- Mkt cap
- 46.84M
- Vol
- 1.00K
- Avg vol
- 156
- EPS
- 1.89
- P/E
- 0.42
More statistics
- Low
- 0.80
- High
- 0.80
2Y chart
Events in this range
- Oct 21, 2025Split: 1 for 50
Signals (136)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Jul 9, 2026 | 3 months ago |
| RSI: Oversold | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| RSI: Overbought | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| RSI: Overbought | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 6, 2026 | 10 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
Newest 20 of 136.
News
- Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting
- Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000
- Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API
- Noveris Health Sciences Inc. Unaware of Any Material Change
- Noveris Health Sciences Joins BioAlberta
- Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)
- Noveris Health Sciences Joins Life Sciences BC
- Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice
- Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board
- Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives
Your note
Sign in to keep a note on MYCOF — it syncs with the Stock Master app.